PROMEDIX, INC.

Profile

Company Names

PROMEDIX, INC.

Addresses

4640 SW MACADAM AVENUE, SUITE 200, PORTLAND, OR 97239

Phone Numbers

503-961-5787

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2018

State Incorporated:

OREGON

Total Amount Raised:

$922,778.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2024-12-02 
$200,000.00 
$200,000.00 
$0.00 
 
3
2022-10-31 
$162,778.00 
$162,778.00 
$0.00 
Debt 
2
2022-10-17 
$310,000.00 
$310,000.00 
$0.00 
Equity 
1
2021-04-09 
$250,000.00 
$250,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
STEVEN 
 
BAKER 
EXECUTIVE OFFICER
LASERLIKE, INC.   |  PROMEDIX, INC.
SCOTT 
 
FILER 
EXECUTIVE OFFICER, DIRECTOR
PROMEDIX, INC.
MATTHEW 
 
HANSEN 
EXECUTIVE OFFICER, DIRECTOR
HANKAR PARTNERS LP   |  APPETIZE TECHNOLOGIES, INC.   |  PROMEDIX, INC.   |  MOUNTAINTOP STUDIOS, INC.   |  GROWERS EDGE FINANCIAL, INC.
ROBERT 
 
JENKS 
EXECUTIVE OFFICER
PROMEDIX, INC.
ANDREW 
 
KIBLER 
EXECUTIVE OFFICER, DIRECTOR
PROMEDIX, INC.
DAVID 
 
SHERIDAN 
EXECUTIVE OFFICER, DIRECTOR
PROMEDIX, INC.   |  HI-TECH SYSTEMS, LLC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2024-12-17
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2024-12-02 
2023-09-11
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2022-10-31 
2023-09-11
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-10-17 
2022-10-31
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2022-10-31 
2022-10-31
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-10-17 
2021-04-23
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-04-09 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#